Drug intelligence / Profile preview

penicillin + gentamicin + amoxicillin

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

The combination of penicillin, gentamicin, and amoxicillin represents an antibiotic regimen that has been studied and used in various clinical contexts. This combination leverages the synergistic effects between beta-lactam antibiotics (penicillin and amoxicillin) and aminoglycosides (gentamicin). ## Description This is a combination antibiotic therapy that pairs beta-lactam antibiotics (penicillin and amoxicillin) with an aminoglycoside (gentamicin). The combination demonstrates synergistic effects against various bacterial infections, particularly in treating severe infections like pneumococcal pneumonia, enterococcal infections, and neonatal sepsis[1][6][8]. Beta-lactam antibiotics cause non-fatal damage to bacterial cell walls, which promotes aminoglycoside entry into bacteria and enhances their killing ability[10]. This synergistic mechanism allows for more effective bacterial clearance, expanded treatment scope, and potentially reduced development of antibiotic resistance[10]. The World Health Organization recommends gentamicin in combination with benzylpenicillin, ampicillin, or amoxicillin as first-choice treatment for sepsis in neonates and children[5]. Studies have shown that oral amoxicillin plus gentamicin regimens may be superior to procaine-penicillin plus gentamicin regimens for treating young infants with possible serious bacterial infections when hospital referral is not feasible[3].

02

Targets

30S A-site (Bacterial ribosomal 30S A-site)PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on penicillin + gentamicin + amoxicillin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on penicillin + gentamicin + amoxicillin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call